Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Novel Immunotherapy Demonstrates Early Potential to Overcome Resistance to Immune Checkpoint Therapy

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the potential to overcome treatment resistance to anti-PD-1 immune checkpoint inhibitors in multiple cancer types.

January 13, 2026


January 22 2026

January 21 2026

January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026